<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05015751</url>
  </required_header>
  <id_info>
    <org_study_id>2020-01</org_study_id>
    <nct_id>NCT05015751</nct_id>
  </id_info>
  <brief_title>Assessment of CSF Shunt Flow With Thermal Measurements</brief_title>
  <official_title>Assessment Of Flow In Cerebrospinal Fluid Shunts With A Wireless Thermal Anisotropy Measurement Device: Phase A</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rhaeos, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rhaeos, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the performance of a non-invasive thermal measurement device for&#xD;
      assessing CSF shunt flow. Patients with an existing implanted shunt and symptoms of shunt&#xD;
      malfunction will be evaluated with the study device.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with an existing implanted ventriculoperitoneal (VP) shunt and who are experiencing&#xD;
      shunt malfunction symptoms will be recruited by the clinical investigators at each&#xD;
      investigational site in accordance with the inclusion and exclusion criteria. Assessment of&#xD;
      shunt flow will be performed non-invasively with the study device; physician and clinical&#xD;
      staff will be blinded to the device result. Standard-of-care assessment of shunt function&#xD;
      will be performed and surgical intervention will occur based on the judgement of the treating&#xD;
      neurosurgeon without the use of study device data. This trial will evaluate the ability of&#xD;
      the study device to identify shunt malfunctions in need of surgical revision.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 25, 2021</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic Performance</measure>
    <time_frame>14-day follow-up period</time_frame>
    <description>accuracy of study device output as a predictor of surgical shunt revision</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Hydrocephalus</condition>
  <arm_group>
    <arm_group_label>Hydrocephalus Patients</arm_group_label>
    <description>Hydrocephalus patients with an existing ventriculoperitoneal shunt and symptoms of a shunt malfunction.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Thermal Anisotropy Measurement Device</intervention_name>
    <description>A wireless device for non-invasively assessing CSF shunt flow.</description>
    <arm_group_label>Hydrocephalus Patients</arm_group_label>
    <other_name>FlowSense</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        hydrocephalus patients with an existing ventriculoperitoneal shunt and shunt malfunction&#xD;
        symptoms&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Existing ventriculoperitoneal CSF shunt&#xD;
&#xD;
          -  At least one symptom of shunt malfunction as determined by the investigator, including&#xD;
             seizure, fever, headache, vision problems, dizziness, disorientation, confusion,&#xD;
             vomiting, lethargy, irritability, difficulty waking or staying awake, swelling along&#xD;
             shunt tract, enlargement of head, loss of balance, gait disturbance, and loss of&#xD;
             sensory or motor function&#xD;
&#xD;
          -  Suspicion of shunt obstruction warrants the performance of a test for this condition&#xD;
             in the investigator's judgement&#xD;
&#xD;
          -  Region of intact skin overlying an unambiguously identifiable chronically indwelling&#xD;
             ventricular shunt which crosses the clavicle and is appropriate in size for&#xD;
             application of the study device&#xD;
&#xD;
          -  Available for follow-up for up to fourteen days&#xD;
&#xD;
          -  Signed informed consent by patient or a parent, legal guardian, health care agent, or&#xD;
             legally authorized representative.&#xD;
&#xD;
          -  Verbal assent by minors four years of age and older who are able to understand the&#xD;
             study and communicate their decision&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of multiple shunts, or presence of more than one distal shunt catheter&#xD;
             (regardless of function) crossing the clavicle ipsilateral to the shunt with suspected&#xD;
             obstruction&#xD;
&#xD;
          -  Use of the study device would interfere with standard patient care, or emergency&#xD;
             surgery that cannot be delayed&#xD;
&#xD;
          -  Presence of an interfering open wound or edema over any portion of the shunt&#xD;
&#xD;
          -  Patient-reported history of adverse skin reactions to adhesives&#xD;
&#xD;
          -  Investigator judges that the subject is likely to be lost to follow-up due to&#xD;
             unavailability or clinical outcome being unobtainable&#xD;
&#xD;
          -  Participation in the study will interfere with, or be detrimental to, administration&#xD;
             of optimal health-care to the subject&#xD;
&#xD;
          -  Prior enrollment in this study (multiple enrollments of the same patient are&#xD;
             disallowed)&#xD;
&#xD;
          -  Participation in any other investigational procedural, pharmaceutical, and/or device&#xD;
             study that may influence the collection of valid data under this study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sandi Lam</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ann &amp; Robert H Lurie Children's Hospital of Chicago</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anna Somera</last_name>
    <phone>855-814-3569</phone>
    <email>info@rhaeos.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>UCSF Benioff Children's Hospital</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94158</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shivani Mahuvakar</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ann &amp; Robert H. Lurie Children's Hospital of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klaudia Dziugan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwestern Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Amidei</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>August 10, 2021</study_first_submitted>
  <study_first_submitted_qc>August 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2021</study_first_posted>
  <last_update_submitted>November 11, 2021</last_update_submitted>
  <last_update_submitted_qc>November 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocephalus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

